Controlled Substances Act 1984

The Act casts a wide net. Primary regulated actors include:

• Health practitioners: medical practitioners, nurse practitioners, dentists, midwives, nurses, pharmacists and veterinary surgeons (defined in s 4 by reference to the Health Practitioner Regulation National Law). They may prescribe, supply, administer or possess scheduled substances only within the ordinary course of their profession or under ministerial authority (ss 13–15, 18, 18A). Endorsements under s 94 of the National Law further delineate authority.

• Manufacturers, wholesalers, retailers and importers of poisons, medicines and medical devices must hold licences or act through authorised practitioners (Part 4). Automatic vending machines are generally prohibited (s 20).

• Poppy industry participants: licensed growers and processors of alkaloid poppies, their employees, associates and contractors (Part 4A). The “fit and proper person” test (s 30C) excludes those with recent serious or drug-related convictions. Contracts must be registered on the alkaloid poppy register (s 30ZZH). Inspectors (including Victorian inspectors and police) exercise entry, sampling and destruction powers.

• Researchers and analysts: may obtain ministerial permits (s 56) or operate under accredited assessment/treatment services (s 56A).

• Law-enforcement officers: authorised officers (s 50), senior police officers who authorise drug-detection operations (ss 52A–52B), and the Commissioner of Police who receives criminal-intelligence classifications (s 30ZZM) and manages the destruction or forfeiture of seized property (s 52E).

• Children and young people: subject to the youth-treatment-order regime (Part 7A) and elevated offences when they are the victims of supply (Div 3 of Part 5). A child cannot be prosecuted for an offence against that Division (s 33E(1)).

• General public: anyone who possesses, uses, cultivates or supplies controlled substances faces criminal liability. Simple cannabis possession may be diverted (Part 5 Div 6). Possession of prescribed equipment or instructions without reasonable excuse is an offence (ss 33LA, 33LAB).

• Courts and tribunals: the Magistrates Court, District Court, Youth Court and SACAT exercise sentencing, review and forfeiture jurisdictions. The Youth Court’s paramount consideration is the child’s best interests (s 54A).

• Minister and Department: the Minister grants licences, issues prohibition orders, publishes warnings, requires information and accredits services. The Chief Executive administers the poppy licensing scheme and maintains the register.

Compliance professionals, corporate risk officers and agricultural consultants advising on poppy contracts are indirectly affected through due-diligence obligations (s 30ZZC).

Duties

• Licence holders (including poppy licensees) must comply with every term and condition, maintain risk-management plans, employ only suitable staff, keep detailed records, report changes of associates or insolvency events within seven business days (s 30ZU), surrender licences on suspension or cancellation (s 30ZV), and prevent unauthorised access to premises (s 30ZX). Licensed processors must hold current Commonwealth narcotic licences (s 30Q(8)).

• Practitioners must not prescribe or supply drugs of dependence for long-term use or to dependent persons without ministerial authority (s 18A). They must retain forged prescriptions and deliver them to police (s 30(3)).

• Sellers of precursors (ss 17B–17C) must obtain end-user statements, verify identity with photographic ID, keep records for five years, check stock after each sale by an independent person, and report suspicious orders to the Commissioner of Police.

• All persons must not manufacture, sell or possess scheduled substances except under statutory exceptions or licences. The onus of proving an exception lies on the defendant (ss 13(3), 18(4), 31(2)).

• Parents, guardians and advocates of children subject to youth orders have rights to notice and to make submissions (s 54D(5)), but the child’s best interests remain paramount.

Rights

• Review and appeal: SACAT reviews refusal, suspension or cancellation of poppy licences (s 30ZZL), Ministerial prohibition orders (s 57(5)) and certain decisions under applied Commonwealth laws (s 11L). The Tribunal may sit with assessors having relevant expertise.

• Natural justice and confidentiality: criminal-intelligence material used to oppose a poppy licence may be withheld from the applicant (s 30ZZM). Self-incrimination is protected in Part 4A inspections (s 30ZP). Confidentiality of diversion-assessment information is strictly maintained (s 40A).

• Diversion: adults alleged to have committed a simple possession offence (other than prescribed drugs) must be referred to an accredited assessment service before prosecution can proceed (s 36). Successful completion of an undertaking confers immunity (s 40(4)).

• Evidentiary rights: defendants are entitled to independent analysis of samples taken from destroyed seized material (s 52E(4)(b)). Certificates of analysis are prima-facie evidence but may be challenged (s 61).

• Youth safeguards: children subject to detention orders must receive family visits, education, daily medical review, nursing presence and a visitor-scheme monitor (s 54L). Legal representation is provided at no cost (s 54M).

Penalties are graduated by quantity, culpability and aggravating factors.

• Life imprisonment applies to trafficking or manufacture of large commercial quantities (ss 32(1), 33(1), 33B(1), 33C(1)) and to supply to children or in school zones (ss 33F, 33G).

• 25 years is the headline maximum for commercial-quantity trafficking or manufacture by non-serious offenders; serious drug offenders face life (s 32(2), s 33(2)).

• 15 years for basic trafficable-quantity offences; 25 years if aggravated (s 32(2a), (3)).

• 10 years for simple supply or administration of non-cannabis controlled drugs (s 33I(1)); lower maxima apply to cannabis (s 33I(2)), cultivation (s 33K) and possession (s 33L).

• Fines only for many Part 4 regulatory breaches ($10 000) and for simple cannabis possession ($2 000).

Aggravating circumstances (s 43) include commission for or in association with a criminal organisation, or displaying its insignia. Courts must consider the nature and quantity of the substance, the offender’s motive and any financial gain when fixing penalty (s 44). Cumulative sentencing is required where a firearm is used in connection with an indictable drug offence unless “special reasons” exist (s 44(3)).

Enforcement tools include:

• Expiation for minor cannabis offences (s 45A) and prescribed Part 4A offences (s 30ZQ).
• Forfeiture of seized drugs, equipment or poppy material (s 52E(7)).
• Destruction of dangerous or hydroponic equipment pre-trial (s 52E(2)).
• Civil recovery of destruction costs (s 52E(6a)).
• Injunctions prohibiting repeat offenders from carrying on businesses (s 33T).
• Youth detention as a last resort, limited in duration and subject to frequent judicial review (s 54I).

Authorised officers (police and appointed inspectors) enjoy entry, search, seizure and sampling powers, exercisable with or without warrant in licensed premises or during business hours in certain non-residential premises (s 52). Drug-detection dogs and electronic systems may be used in licensed premises, public venues and authorised public places (s 52A) or on declared drug-transit routes (s 52B). Obstruction attracts up to two years’ imprisonment (s 52D(3)).

The Act is expressly additional to, and does not derogate from, any other statute (s 5(2)). It interacts with:

• Commonwealth therapeutic goods legislation via Part 2A. The Therapeutic Goods Act 1989 (Cth) and its regulations apply as South Australian law, modified to substitute state courts and tribunals and to extend to natural persons and intra-state activity. Fees paid to the Commonwealth Secretary may be retained by the Commonwealth (s 11E). No double jeopardy arises where conduct offends both regimes (s 11K).

• Industrial Hemp Act 2017 (SA): cultivation and supply of industrial hemp is carved out of the controlled-plant offences (s 31(1)(ah)–(ai)).

• Criminal Law Consolidation Act 1935 (SA): the definition of “criminal organisation” for aggravated offences is borrowed from Part 3B (s 43(5)). Accessorial liability under s 267 is excluded for principal trafficking, manufacture and controlled-drug-alternative offences (s 33S). Firearm offences committed in connection with indictable drug offences attract mandatory cumulative sentencing (s 44(3)).

• South Australian Civil and Administrative Tribunal Act 2013: SACAT reviews poppy-licence decisions (s 30ZZL), certain Ministerial orders (s 57(5)) and applied-Commonwealth-law reviews (s 11L). The Tribunal may sit with specialist assessors (s 11L).

• Expiation of Offences Act 1996: used for simple cannabis offences and prescribed Part 4A expiable offences.

• Youth Justice Administration Act 2016 and Children and Young People (Safety) Act 2017: supply the visitor scheme, training-centre infrastructure and child-protection interface for Part 7A orders.

• Local Government Act 1999: inspectors may access ratepayer information to locate licensed poppy premises (s 30ZO).

• Public Sector (Honesty and Accountability) Act 1995: Advisory Council members are not taken to have a conflict merely by virtue of their general interest in the regulated industries (s 10A).

The Act preserves civil remedies (s 5(3)) and does not limit common-law possession concepts beyond the statutory extension to control and joint possession (s 4(1)).

Since 1984 the Act has been amended more than 40 times. Major recent changes illustrate a shift from pure prohibition toward regulated industry, harm minimisation and procedural fairness.

• 2011 Therapeutic Goods amendments (Controlled Substances (Therapeutic Goods and Other Matters) Amendment Act 2011): inserted Part 2A to apply Commonwealth laws locally, avoiding regulatory duplication and ensuring uniform national standards for medicines and devices. The change responded to the need for seamless regulation after the Therapeutic Goods Act 1989 (Cth) was substantially updated.

• 2013 controlled-drug-alternatives regime (Controlled Substances (Offences) Amendment Act 2013): created Div 4A to close the “legal high” loophole. Police warning notices (s 33LF) allow swift prohibition of substances promoted as drug substitutes. The reform was driven by the rapid emergence of synthetic cannabinoids and cathinones.

• 2015 poppy cultivation licensing (Controlled Substances (Poppy Cultivation) Amendment Act 2015): responded to the Tasmanian and Victorian poppy-straw industries and the Commonwealth’s narcotic-drugs licensing framework. Part 4A imposes a strict “fit and proper person” test, criminal-intelligence safeguards and a register to prevent diversion to the illicit market while enabling a legitimate pharmaceutical supply chain.

• 2015–2016 simple-possession diversion (Controlled Substances (Simple Possession Offences) Amendment Act 2015): replaced the former assessment-panel system with direct referral to accredited services, removed the two-strike limit for adults, and clarified confidentiality (s 40A). The aim was to reduce criminalisation of minor cannabis use and increase treatment uptake.

• 2018–2019 serious-drug-offender and youth-treatment reforms: the Statutes Amendment (Drug Offences) Act 2018 expanded the “serious drug offender” definition (now s 4(7a)) and aligned penalties. The Controlled Substances (Youth Treatment Orders) Amendment Act 2019 introduced Part 7A, giving the Youth Court compulsory assessment, treatment and detention powers where children are at risk. The “best interests” paramountcy (s 54A) and detailed safeguarding provisions reflect contemporary child-rights jurisprudence and the Royal Commission into the Protection of Children.

• 2020 confidentiality amendments (Controlled Substances (Confidentiality and Other Matters) Amendment Act 2020): strengthened s 60A and aligned it with other health-information statutes after privacy breaches.

• 2022 pure-amount amendments (Controlled Substances (Pure Amounts) Amendment Act 2022): clarified that quantity calculations for mixtures apply the pure-drug threshold when the charge so alleges, applying retrospectively from 2009 to resolve charging inconsistencies.

• 2024 destruction-of-seized-property amendments: expanded Commissioner powers to destroy hydroponic equipment pre-trial and recover costs, addressing storage burdens and environmental risks.

These changes reflect evolving Commonwealth–State coordination, the pharmaceutical opportunities presented by poppy straw, evidence that criminalising minor cannabis use is counterproductive, and growing recognition that compulsory treatment for young people must be tightly safeguarded.

Although the Act has generated comparatively few constitutional challenges, several recurring issues have reached the courts.

The presumptions of intention once a trafficable quantity is proved (ss 32(5), 33(4), 33B(5)) have been upheld as evidential rather than legal presumptions that do not reverse the legal burden of proof (R v Rowse (2007) 97 SASR 257). Courts have emphasised that the defendant may adduce evidence to negative the presumed intent.

The validity of the poppy-licensing regime’s criminal-intelligence provisions (s 30ZZM) has not yet been squarely tested, but analogous Victorian and Tasmanian schemes have survived natural-justice challenges on the basis that the public-interest override is proportionate (Kable v Director of Public Prosecutions (NSW) principles have not been engaged because the functions remain judicially reviewable by SACAT).

Youth-treatment-order detention has raised Charter and human-rights concerns in analogous interstate jurisdictions. South Australian courts must balance the child’s best interests against the right to liberty. The requirement for frequent judicial review (s 54I) and medical oversight (s 54L) appears designed to meet Kable and Totani standards.

Sentencing controversies centre on the statutory direction that all controlled drugs (other than cannabis) are to be treated as equally harmful (s 44(2)). This has produced calls for legislative reform from judges who consider MDMA less harmful than methamphetamine, but the Court of Appeal has consistently applied the statutory mandate (R v Nguyen (2015) 124 SASR 46).

The interaction between the Act and the Criminal Assets Confiscation Act 2005 has produced litigation over whether financial-gain evidence used for sentencing can also found a confiscation application. Section 44(1)(d)(ii) now expressly prevents double-counting.

Administrative-law challenges to Ministerial prohibition orders (s 57) and licence cancellations have succeeded where procedural fairness was denied or where the Minister took into account irrelevant criminal-intelligence material without giving the applicant an opportunity to respond in a redacted form. SACAT’s jurisdiction to conduct merits review has largely resolved these disputes.

Most practitioners are surprised by the following:

1. The “mixture” rule and pure-amount amendments (s 33OA, retrospective from 2009). A charge that simply alleges “X grams of methylamphetamine” will be measured against the pure-drug threshold even if the substance was in fact a mixture. Prosecutors must now particularise whether they rely on pure or mixed thresholds; failure can lead to acquittal on quantity.

2. Employee due-diligence liability (s 30ZZC). A licensed poppy grower or processor commits the same offence as an employee if the licensee failed to exercise due diligence. The defence mirrors the employee’s but the onus remains on the licensee. Internal training records and supervision logs are therefore critical.

3. Criminal-intelligence non-disclosure (s 30ZZM). If the Commissioner classifies information as criminal intelligence, the Chief Executive may refuse a poppy licence stating only that the decision is in the public interest. SACAT review occurs in closed session without the applicant. Applicants must therefore lodge the most complete character and financial material at first instance.

4. Section 18A(1) “two-month rule”. A practitioner who knows a patient has already received drugs of dependence from another practitioner for longer than two months in aggregate cannot prescribe without Ministerial authority, even if each individual prescription was for less than two months. The knowledge threshold is “reasonable cause to believe”.

5. Simple-possession diversion is not available if the person has been referred twice in the previous four years (s 34(1)(c)). Police and practitioners must check the central referral database before deciding whether to charge or divert.

6. Hydroponic equipment seized under s 52E(2)(c) can be destroyed immediately. The owner loses the right to return of the equipment even if ultimately acquitted, although costs of destruction cannot be recovered if the seizure predates the 2024 amendments.

7. Youth Court orders survive the child’s 18th birthday unless the Court specifies otherwise (s 54J). Treatment or detention can continue into adulthood, raising jurisdictional questions about adult detention facilities that have not yet been litigated.

8. The Advisory Council’s annual report (s 11(6)–(7)) is a statutory trigger for parliamentary scrutiny. Compliance professionals should monitor it for foreshadowed scheduling changes.

For health practitioners and pharmacists:

• Maintain a current registration and any required s 94 endorsement.
• Document every long-term or dependent-patient prescription and obtain Ministerial authority where s 18A(1) is engaged.
• Retain prescriptions for two years and report forgeries immediately (s 30(3)).
• Use only software that generates compliant labels and keep batch records for compounded medicines.

For poppy licensees:

• Submit a comprehensive risk-management plan with the application and update it whenever the Chief Executive requires (s 30G(4)).
• Conduct police-record checks on all associates before lodging the application.
• Register every contract on the alkaloid poppy register within seven days (s 30ZZH).
• Issue photographic employee ID cards before any work commences (ss 30J, 30T) and ensure employees carry them on-site.
• Implement physical security (locked gates, CCTV, signage) and maintain an audit trail of every movement of poppy material.
• Report any associate change, bankruptcy or new offence within seven business days (s 30ZU).

For manufacturers and wholesalers:

• Hold a current licence or act through an authorised practitioner.
• Conduct batch analysis, retain samples and ensure every package meets the labelling and child-resistant-closure standards prescribed by regulation.
• Keep movement records for five years and make them available to authorised officers on demand.

For corporate counsel and compliance officers:

• Map every controlled substance used in the business against the current schedules (available on the SA legislation website and updated after each Advisory Council recommendation).
• Maintain a central register of all licences, permits and authorities, with automated expiry reminders.
• Implement a suspicious-order detection algorithm for precursor sales and train staff to report to police within 24 hours (s 17B(3)).
• Conduct annual mock inspections using the powers set out in ss 30ZB and 52.
• For youth-facing organisations, develop protocols to identify children who may meet the s 54D criteria and refer them to the Youth Court or an accredited service rather than self-managing.

General compliance checklist:

• Never rely on “I didn’t know it was a controlled drug”—recklessness is sufficient mens rea (s 33P).
• If a substance is promoted as a “legal high”, treat any police warning notice under s 33LF as an absolute prohibition.
• For seized material that is destroyed, request a sample for independent analysis immediately (s 52E(4)).
• Keep verbatim records of all Ministerial or Chief Executive notices; they are often expressed to take effect on service, and service can occur by email (s 55(4a)).

Organisations that integrate these requirements into an ISO 37301-compliant compliance management system, supported by annual training and internal audit, materially reduce both regulatory and criminal risk.